Composition for treating asthenopia of video terminal as well as preparation method and application of composition
Through the combination of 'liver-clearing and eye-enhancing medicine + liver-tonifying medicine + kidney-tonifying medicine + yang-warming medicine', an appropriate dosage form of drugs was prepared, which solved the problems of short time and poor efficacy of existing visual fatigue drugs for treating video terminals, and achieved the Significantly improves the effectiveness of visual fatigue symptoms and reduces the cost of use.
Patent Information
- Application Number
- CN202411410476.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-10
- Publication Date
- 2024-12-06
AI Technical Summary
Existing drugs for treating visual fatigue at the terminal of the video screen are difficult to cure the symptoms, and the short time and frequent use of eye drops will aggravate the discomfort such as dry eyes. Traditional Chinese medicine methods are diverse but the efficacy is inconsistent.
Using the combination of 'liver-clearing and eye-enhancing medicine + liver-tonifying medicine + kidney-tonifying medicine + yang-warming medicine', it is made into appropriate dosage forms through Chinese herbal medicines such as tea, red and green grass, dog bones, white peony, fairy grass and walnut kernels. Drugs are extracted by simulating the pH value of the human stomach and small intestine to form a combination of gastric juice and small intestine fluid, which is used to treat visual fatigue at the terminal of the video screen.
It significantly improves the patient's visual fatigue symptoms, with a total effective efficiency of 95.6%, which is more efficient than 84.4% of combined use of Western medicine, and is convenient to use, reduces the cost, and reduces the use of Chinese medicine flavors.
Smart Images

Figure BDA0005077842400000101 
Figure BDA0005077842400000191 
Figure BDA0005077842400000192
Abstract
Description
Technical Field
[0001] The present invention relates to the field of traditional Chinese medicine, and in particular to a composition for treating visual fatigue of video terminals, and a preparation method and application thereof. Background Art
[0002] Visual terminal visual fatigue refers to a syndrome characterized by a series of visual fatigue symptoms in operators due to long-term staring at electronic screens (such as display screens, monitors, mobile phones, computers and other video display terminals). Staring at electronic screens for a long time will cause overuse and continuous tension of the visual organs, and eventually exceed their compensatory capacity and cause the disease. The occurrence of this disease is related to eye factors (such as refractive error, dry eyes), video terminal factors (such as display image quality, blue light, long operation time) and systemic factors (such as age, nerves), which will not only reduce the patient's work efficiency and quality, but also cause a series of psychological diseases.
[0003] Studies have shown that visual fatigue caused by video terminals is four times that of ordinary workers, and 90% of digital device users have different degrees of visual fatigue symptoms. In my country, the incidence of video terminals is showing a trend of widespread and younger age. The main manifestations are dry eyes, foreign body sensation, blurred vision, eye swelling, tearing, photophobia, heavy eyelids, etc., which may lead to cataracts in severe cases. The longer the video terminal is used, the more severe the above symptoms. With the increasing application of video display terminals, their impact on the operator's eyes has received great attention. Improving the working and living environment cannot be ignored, and visual fatigue that is difficult to recover from rest should be treated with drugs.
[0004] Western medicine mainly treats this disease with eye drops, and can also be combined with some eye function training. However, eye drops are mainly antibiotics and have adverse reactions. For example, some eye drops contain preservatives. Long-term use will increase the permeability of the ocular epithelium, thereby reducing the stability of the tear film. They mainly improve symptoms and are difficult to cure. In addition, many eye drops have a short duration of action. Frequent eye drops will wash away normal tear film components, accelerate the evaporation of tears, and aggravate dry eyes and other discomfort. Traditional Chinese medicine has a variety of treatment methods for this disease, and the effect is satisfactory. Common methods include Chinese herbal decoctions, Chinese herbal eye drops and physical therapy. Physical therapy includes acupuncture, moxibustion, massage, auricular acupoint pressing, etc. Nowadays, there are some therapies that combine Chinese medicine with modern technology, such as ion introduction and ultrasonic atomization, which greatly improve the efficacy of this disease.
[0005] According to Chinese medicine, all the pulses belong to the eyes, and the liver receives blood and can see. "Qianjin Yaofang·Qiqiao Diseases" says "overuse of the eyes, such as reading, gambling, etc., is called liver fatigue", which directly attributes this disease to "liver fatigue". Its symptoms include visual fatigue, blurred vision, dry eyes, eye pain, foreign body sensation, red eyes, eye swelling, etc., which are also called "eye fatigue" in contemporary Chinese medicine. Combining the understanding of ancient doctors and current clinical practice, visual fatigue can be divided into three Chinese medicine syndromes: liver and kidney yin deficiency, liver depression and qi stagnation, and qi and blood deficiency, among which liver and kidney yin deficiency is the main syndrome.
[0006] Liver Yin deficiency and kidney Yin deficiency are liver-kidney Yin deficiency. Liver Yin deficiency is often affected by kidney Yin deficiency, and fire is damaged by liver Yin and kidney Yin, resulting in liver-kidney Yin deficiency. The kidney is the place where essence is stored, and the liver is the organ that stores blood. Liver blood depends on the cultivation of kidney essence, and kidney essence depends on the supplement of liver blood. Only when the eyes are nourished by essence and blood can the vision be sharp. When the kidney is deficient, dizziness and blurred vision will occur. After long-term vision, dry and sore eyes will appear, accompanied by dizziness, tinnitus, sore waist and knees, restlessness, night sweats, insomnia and dreaminess. Liver-kidney Yin deficiency is a syndrome in traditional Chinese medicine, which includes liver blood deficiency, liver Yin deficiency, kidney essence deficiency, and kidney Yin deficiency. When the liver and kidney are deficient at the same time, it is necessary to nourish the liver and kidney, but while nourishing the liver blood and kidney Yin, it is also necessary to warm the yang medicine, so that there is yang in the yin and yin in the yang, and the transformation will be powerful.
[0007] In view of the above TCM theory, the team of the present invention adopted the combination of "liver-clearing and eye-improving medicine + liver-tonifying medicine + kidney-tonifying medicine + warming yang medicine" to carry out experimental research, and screened out an effective formula with the effect of relieving visual fatigue of video terminals through the liver and kidney yin deficiency syndrome mouse model. After consulting the research data and combining the clinical medication experience, the preliminary selection of tea and red green grass for liver-clearing and eye-improving medicine, mulberry and dog bone for kidney-tonifying medicine, white peony and cyperus for liver-tonifying medicine, and curculigo and walnut kernel for warming yang medicine in this study. Finally, through experimental screening and investigation, the formula was determined to be 15g tea, 15g red green grass, 15g dog bone, 10g white peony, 10g curculigo, and 15g walnut kernel.
[0008] Tea is a dried product made from the tender leaves or stems of the Camellia sinensis O.Ktze plant of the Theaceae family. It has the effects of soothing the head, relieving thirst, resolving phlegm, promoting urination, and detoxifying. It is used for headaches, dizziness, fatigue, irritability, thirst, etc.
[0009] Red green grass is the whole herb of Alternanthera versicolor Hort.ex Regel, a plant of the Amaranthaceae family. It has the effects of clearing the liver and improving eyesight, cooling blood and stopping bleeding. It is often used for conjunctivitis, dysentery, internal bleeding, blood in the stool, and traumatic injuries.
[0010] Dog bones are the bones of the domestic dog Canisfamiliais, and the limb bones are the best for medicinal use.
[0011] White peony root is the dried root of Paeonia lactiflora Pall., a plant of the Ranunculaceae family. It has the effects of nourishing blood and regulating menstruation, restraining yin and stopping sweating, softening the liver and relieving pain, and calming liver yang. It is used for chlorosis due to blood deficiency, irregular menstruation, spontaneous sweating, night sweats, flank pain, abdominal pain, cramps in the limbs, headache and dizziness, etc.
[0012] Curculigo is the dried rhizome of Curculigo orchioides Gaertn., a plant of the Amaryllidaceae family. It has the effects of tonifying kidney yang, strengthening tendons and bones, and removing cold and dampness. It is used for impotence, cold sperm, weak tendons and bones, cold pain in the waist and knees, and cold diarrhea due to yang deficiency.
[0013] Walnut kernel is the dried mature seed of Juglans regia L., a plant of the Juglandaceae family. It has the effects of nourishing the kidney, warming the lungs, and moistening the intestines. It is used for kidney yang deficiency, soreness of the waist and knees, impotence and spermatorrhea, asthenia and cough due to deficiency and cold, and constipation due to dry intestines. Summary of the invention
[0014] The object of the present invention is to provide a composition for treating visual fatigue in video screen terminals.
[0015] Another object of the present invention is to provide a method for preparing a composition for treating visual fatigue in video screen terminals.
[0016] Another object of the present invention is to provide a composition for treating visual fatigue of video terminals for use in preparing a drug for treating visual fatigue of video terminals.
[0017] The present invention provides a composition for treating visual fatigue of video terminals, which can be prepared into a suitable dosage form through modern pharmaceutical preparation technology, so as to provide a preparation with more significant efficacy, faster onset and more convenient use for clinical treatment of visual fatigue of video terminals.
[0018] The present invention is achieved through the following technical solutions:
[0019] The composition for treating visual fatigue of video terminals of the present invention is composed of the following raw material components by weight: 10-20 parts of tea leaves, 10-20 parts of red and green grass, 10-20 parts of dog bones, 5-15 parts of white peony roots, 5-15 parts of curculigo orchioides, and 10-20 parts of walnut kernels.
[0020] Preferably, the composition of the present invention is composed of the following raw material components by weight: 12-18 parts of tea leaves, 12-18 parts of red green grass, 12-18 parts of dog bones, 6-14 parts of white peony root, 6-14 parts of curculigo, and 12-18 parts of walnut kernels.
[0021] Further preferably, the composition of the present invention is composed of the following raw material components by weight: 14-16 parts of tea leaves, 14-16 parts of red green grass, 14-16 parts of dog bones, 8-12 parts of white peony roots, 8-12 parts of curculigo, and 14-16 parts of walnut kernels.
[0022] More preferably, the composition of the present invention is composed of the following raw material components by weight: 15 parts of tea leaves, 15 parts of red green grass, 15 parts of dog bones, 10 parts of white peony roots, 10 parts of curculigo, and 15 parts of walnut kernels.
[0023] The present invention discloses a method for preparing a composition for treating visual fatigue of a video terminal. The medicinal materials of tea, red green grass, dog bone, white peony root, curculigo orchioides and walnut kernel are weighed according to the proportion of the formula, 6-10 times of water are first added to simulate the pH value of human stomach, the pH of the extractant is adjusted to 2.0 with 1mol / L HCL, heating and extracting for 0.5-1.5h, filtering to obtain a simulated gastric juice extract, 6-10 times of water are added to the residue to simulate the pH value of human small intestine, the pH of the extractant is adjusted to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heating and extracting for 0.5-1.5h, filtering, combining the two filtrates, concentrating, adding conventional pharmaceutical excipients to prepare a corresponding preparation.
[0024] Preferably, the preparation method of the composition for visual fatigue of video terminals described in the present invention comprises the following steps: weighing tea leaves, red green grass, dog bones, white peony root, curculigo orchioides, and walnut kernel medicinal materials according to the formula ratio, first adding 6 times of water to simulate the pH value of human stomach, adjusting the pH of the extractant to 2.0 with 1 mol / L HCL, heating and extracting for 1.5 hours, filtering, and obtaining a simulated gastric juice extract, adding 6 times of water to the residue to simulate the pH value of human small intestine, adjusting the pH of the extractant to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heating and extracting for 1.5 hours, filtering, combining the two filtrates, concentrating, and adding conventional pharmaceutical excipients to prepare a pharmaceutically acceptable preparation.
[0025] The pharmaceutically acceptable preparation of the present invention is a solid preparation or a liquid preparation.
[0026] The pharmaceutical preparation of the present invention is prepared into a pharmaceutically acceptable preparation by adding pharmaceutically acceptable excipients.
[0027] The solid preparations of the present invention include, but are not limited to, granules, capsules, tablets, and pills.
[0028] The liquid preparations of the present invention include, but are not limited to, decoctions and mixtures.
[0029] The composition of the present invention or the product prepared by the preparation method is used in preparing a drug for treating visual fatigue of video terminals.
[0030] Compared with the prior art, the present invention has the following beneficial effects:
[0031] 1. The drug for treating visual fatigue caused by video terminals obtained by screening and investigation in the present invention is a new drug, which has the effects of nourishing the liver and kidneys, improving essence and improving eyesight, and can be used to treat dry eyes, foreign body sensation, blurred vision, eye swelling, tearing, photophobia, heavy eyelids, etc. caused by visual fatigue caused by video terminals.
[0032] 2. The formula has obvious therapeutic effect. The clinical efficacy verification results show that the total effective rate of the drug of the present invention combined with western medicine is 95.6%, which is significantly different from the total effective rate of 84.4% in the control group, indicating that the present invention can effectively improve the clinical symptoms of patients and improve their quality of life.
[0033] 3. It is more convenient to carry and take. After the medicine of the present invention is made into a preparation (granules, oral liquid, etc.), it is more convenient for patients to take, carry and store it compared with taking it in decoction.
[0034] 4. The present invention reduces the use of Chinese medicinal ingredients in the prescription, has equivalent therapeutic effects, and reduces costs. DETAILED DESCRIPTION
[0035] The technical solution of the present invention is further described in detail below through specific embodiments.
[0036] Example 1 A drug for treating visual fatigue in video terminals
[0037] Recipe: 15g tea leaves, 15g red and green grass, 15g dog bones, 10g white peony root, 10g curculigo, and 15g walnut kernels.
[0038] Example 2 A drug for treating visual fatigue in video terminals
[0039] Recipe: 10g tea leaves, 10g red green grass, 10g dog bones, 5g white peony root, 5g curculigo, and 10g walnut kernels.
[0040] Example 3 A drug for treating visual fatigue in video terminals
[0041] Recipe: 20g tea leaves, 20g red and green grass, 20g dog bones, 5g white peony root, 5g curculigo, and 20g walnut kernels.
[0042] Example 4: A drug for treating visual fatigue in video terminals
[0043] Recipe: 15g tea leaves, 15g red and green grass, 10g dog bones, 10g white peony root, 10g curculigo, and 20g walnut kernels.
[0044] Example 5: A drug for treating visual fatigue in video terminals
[0045] Recipe: 15g tea leaves, 20g red and green grass, 15g dog bones, 15g white peony root, 5g curculigo, and 10g walnut kernels.
[0046] Example 6 A drug for treating visual fatigue in video terminals
[0047] Recipe: 20g tea leaves, 15g red green grass, 15g dog bones, 10g white peony root, 10g curculigo, and 10g walnut kernel.
[0048] Example 7 A drug for treating visual fatigue in video terminals
[0049] Recipe: 12g tea leaves, 12g red and green grass, 12g dog bones, 6g white peony root, 6g curculigo, and 12g walnut kernels.
[0050] Example 8 A drug for treating visual fatigue in video terminals
[0051] Recipe: 18g tea leaves, 18g red and green grass, 18g dog bones, 14g white peony root, 14g curculigo, and 18g walnut kernels.
[0052] Example 9: A drug for treating visual fatigue in video terminals
[0053] Recipe: 14g tea leaves, 14g red and green grass, 14g dog bones, 8g white peony root, 8g curculigo, and 14g walnut kernels.
[0054] Example 10 A drug for treating visual fatigue in video terminals
[0055] Recipe: 16g tea leaves, 16g red and green grass, 16g dog bones, 12g white peony root, 12g curculigo, and 16g walnut kernels.
[0056] The formulations of Examples 1-10 are used in the preparation methods of the following examples.
[0057] Example 11 A method for preparing a drug for treating visual fatigue in video terminals (mixture)
[0058] (1) Extraction: Take tea leaves, red green grass, dog bones, white peony root, curculigo orchioides, and walnut kernels according to the formula, first add 6 times of water to simulate the pH value of human stomach, adjust the pH of the extract to 2.0 with 1 mol / L HCL, heat and extract for 1.5 h, filter, and obtain gastric juice simulated extract. Add 6 times of water to the residue to simulate the pH value of human small intestine, adjust the pH of the extract to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heat and extract for 1.5 h, filter, and combine the two filtrates.
[0059] (2) Concentration: Concentrate the extract into a thick paste.
[0060] (3) Drying: Add 8g of refined honey and starch to the thick paste, mix well, and dilute with water to make 30ml of the mixture.
[0061] Example 12 A method for preparing a drug for treating visual fatigue in video terminals (capsules)
[0062] (1) Extraction: Take tea leaves, red green grass, dog bones, white peony root, curculigo orchioides, and walnut kernels according to the formula, first add 6 times of water to simulate the pH value of human stomach, adjust the pH of the extract to 2.0 with 1 mol / L HCL, heat and extract for 1.5 h, filter, and obtain gastric juice simulated extract. Add 6 times of water to the residue to simulate the pH value of human small intestine, adjust the pH of the extract to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heat and extract for 1.5 h, filter, and combine the two filtrates.
[0063] (2) Concentration: Concentrate the extract into a thick paste.
[0064] (3) Drying: Add 2 g starch to the thick paste, stir well, and dry at below 80°C.
[0065] (4) Grinding and granulation: The dry paste is crushed into fine powder, granulated with 80% ethanol, and dried.
[0066] (5) Preparation: The granules are packed into capsules.
[0067] Example 13 Preparation method of a drug for treating visual fatigue of video terminals (tablets)
[0068] (1) Extraction: Take tea leaves, red green grass, dog bones, white peony root, curculigo orchioides, and walnut kernels according to the formula, first add 6 times of water to simulate the pH value of human stomach, adjust the pH of the extract to 2.0 with 1 mol / L HCL, heat and extract for 1.5 h, filter, and obtain gastric juice simulated extract. Add 6 times of water to the residue to simulate the pH value of human small intestine, adjust the pH of the extract to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heat and extract for 1.5 h, filter, and combine the two filtrates.
[0069] (2) Concentration: Concentrate the extract into a thick paste.
[0070] (3) Drying: Add 2 g starch to the thick paste, stir well, and dry at below 80°C.
[0071] (4) Grinding and granulation: The dry paste is crushed into fine powder, granulated with 80% ethanol, and dried.
[0072] (5) Preparation: The granules are compressed into tablets.
[0073] Example 14 Preparation of a drug for treating visual fatigue in video terminals (granules)
[0074] (1) Extraction: Take tea leaves, red green grass, dog bones, white peony root, curculigo orchioides, and walnut kernels according to the formula, first add 6 times of water to simulate the pH value of human stomach, adjust the pH of the extract to 2.0 with 1 mol / L HCL, heat and extract for 1.5 h, filter, and obtain gastric juice simulated extract. Add 6 times of water to the residue to simulate the pH value of human small intestine, adjust the pH of the extract to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heat and extract for 1.5 h, filter, and combine the two filtrates.
[0075] (2) Concentration: Concentrate the extract into a thick paste.
[0076] (3) Preparation: Add appropriate amount of soluble starch to the thick paste, granulate, dry, and shape the particles to make granules.
[0077] Example 15 Preparation of a drug for treating visual fatigue in video terminals (granules)
[0078] (1) Extraction: Take tea leaves, red green grass, dog bones, white peony root, curculigo orchioides, and walnut kernels according to the formula, first add 8 times of water to simulate the pH value of human stomach, adjust the pH of the extractant to 2.0 with 1 mol / L HCL, heat and extract for 1.0 h, filter, and obtain gastric juice simulated extract. Add 8 times of water to the residue to simulate the pH value of human small intestine, adjust the pH of the extractant to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heat and extract for 1.0 h, filter, and combine the two filtrates.
[0079] (2) Concentration: Concentrate the extract into a thick paste.
[0080] (3) Preparation: Add appropriate amount of soluble starch to the thick paste, granulate, dry, and shape the particles to make granules.
[0081] Example 16 A method for preparing a drug for treating visual fatigue in video terminals (capsules)
[0082] (1) Extraction: Take tea leaves, red green grass, dog bones, white peony root, curculigo orchioides, and walnut kernels according to the formula, first add 8 times of water to simulate the pH value of human stomach, adjust the pH of the extractant to 2.0 with 1 mol / L HCL, heat and extract for 1.0 h, filter, and obtain gastric juice simulated extract. Add 8 times of water to the residue to simulate the pH value of human small intestine, adjust the pH of the extractant to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heat and extract for 1.0 h, filter, and combine the two filtrates.
[0083] (2) Concentration: Concentrate the extract into a thick paste.
[0084] (3) Drying: Add 3 g starch to the thick paste, stir well, and dry at below 80°C.
[0085] (4) Grinding and granulation: The dry paste is crushed into fine powder, granulated with 80% ethanol, and dried.
[0086] (5) Preparation: The granules are packed into capsules.
[0087] Example 17 A method for preparing a drug for treating visual fatigue of a video terminal (capsule)
[0088] (1) Extraction: Take tea leaves, red green grass, dog bones, white peony root, curculigo orchioides, and walnut kernels according to the formula, first add 10 times of water to simulate the pH value of human stomach, adjust the pH of the extractant to 2.0 with 1 mol / L HCL, heat and extract for 1.5 h, filter, and obtain gastric juice simulated extract. Add 10 times of water to the residue to simulate the pH value of human small intestine, adjust the pH of the extractant to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heat and extract for 1.5 h, filter, and combine the two filtrates.
[0089] (2) Concentration: Concentrate the extract into a thick paste.
[0090] (3) Drying: Add 4 g starch to the thick paste, stir well, and dry at below 80°C.
[0091] (4) Grinding and granulation: The dry paste is crushed into fine powder, granulated with 80% ethanol, and dried.
[0092] (5) Preparation: The granules are packed into capsules.
[0093] Example 18 Preparation method of a drug for treating visual fatigue of video terminals (tablets)
[0094] (1) Extraction: Take tea leaves, red green grass, dog bones, white peony root, curculigo orchioides, and walnut kernels according to the formula, first add 8 times of water to simulate the pH value of human stomach, adjust the pH of the extractant to 2.0 with 1 mol / L HCL, heat and extract for 0.5 h, filter, and obtain gastric juice simulated extract. Add 8 times of water to the residue to simulate the pH value of human small intestine, adjust the pH of the extractant to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heat and extract for 0.5 h, filter, and combine the two filtrates.
[0095] (2) Concentration: Concentrate the extract into a thick paste.
[0096] (3) Drying: Add 2.5 g starch to the thick paste, stir well, and dry at below 80°C.
[0097] (4) Grinding and granulation: The dry paste is crushed into fine powder, granulated with 80% ethanol, and dried.
[0098] (5) Preparation: The granules are compressed into tablets.
[0099] Example 19 A method for preparing a drug for treating visual fatigue in video terminals (tablets)
[0100] (1) Extraction: Take tea leaves, red green grass, dog bones, white peony root, curculigo orchioides, and walnut kernels according to the formula, first add 10 times of water to simulate the pH value of human stomach, adjust the pH of the extractant to 2.0 with 1 mol / L HCL, heat and extract for 1.0 h, filter, and obtain gastric juice simulated extract. Add 6 times of water to the residue to simulate the pH value of human small intestine, adjust the pH of the extractant to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heat and extract for 1.0 h, filter, and combine the two filtrates.
[0101] (2) Concentration: Concentrate the extract into a thick paste.
[0102] (3) Drying: Add 2.5 g starch to the thick paste, stir well, and dry at below 80°C.
[0103] (4) Grinding and granulation: The dry paste is crushed into fine powder, granulated with 80% ethanol, and dried.
[0104] (5) Preparation: The granules are compressed into tablets.
[0105] Example 20 Preparation method of a drug for treating visual fatigue of video terminals (tablets)
[0106] (1) Extraction: Take tea leaves, red green grass, dog bones, white peony root, curculigo orchioides, and walnut kernels according to the formula, first add 10 times of water to simulate the pH value of human stomach, adjust the pH of the extractant to 2.0 with 1 mol / L HCL, heat and extract for 1.5 h, filter, and obtain gastric juice simulated extract. Add 10 times of water to the residue to simulate the pH value of human small intestine, adjust the pH of the extractant to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heat and extract for 1.5 h, filter, and combine the two filtrates.
[0107] (2) Concentration: Concentrate the extract into a thick paste.
[0108] (3) Drying: Add 2 g starch to the thick paste, stir well, and dry at below 80°C.
[0109] (4) Grinding and granulation: The dry paste is crushed into fine powder, granulated with 80% ethanol, and dried.
[0110] (5) Preparation: The granules are compressed into tablets.
[0111] Example 21 A method for preparing a drug for treating visual fatigue in video terminals (compound)
[0112] (1) Extraction: Take tea leaves, red green grass, dog bones, white peony root, curculigo orchioides, and walnut kernels according to the formula, first add 8 times of water to simulate the pH value of human stomach, adjust the pH of the extractant to 2.0 with 1 mol / L HCL, heat and extract for 1.0 h, filter, and obtain gastric juice simulated extract. Add 8 times of water to the residue to simulate the pH value of human small intestine, adjust the pH of the extractant to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heat and extract for 1.0 h, filter, and combine the two filtrates.
[0113] (2) Concentration: Concentrate the extract into a thick paste.
[0114] (3) Drying: Add 10g of refined honey and starch to the thick paste, mix well, and dilute with water to make 30ml of the mixture.
[0115] Example 22 A method for preparing a drug for treating visual fatigue in video terminals (compound)
[0116] (1) Extraction: Take tea leaves, red green grass, dog bones, white peony root, curculigo orchioides, and walnut kernels according to the formula, first add 10 times of water to simulate the pH value of human stomach, adjust the pH of the extractant to 2.0 with 1 mol / L HCL, heat and extract for 1.5 h, filter, and obtain gastric juice simulated extract. Add 10 times of water to the residue to simulate the pH value of human small intestine, adjust the pH of the extractant to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heat and extract for 1.5 h, filter, and combine the two filtrates.
[0117] (2) Concentration: Concentrate the extract into a thick paste.
[0118] (3) Drying: Add 10g of refined honey and starch to the thick paste, mix well, and dilute with water to make 30ml of the mixture.
[0119] Example 23: Preparation of a drug for treating visual fatigue in video terminals (decoction)
[0120] According to the formula, measure tea leaves, red green grass, dog bones, white peony root, curculigo, and walnut kernels, first add 6 times of water to simulate the pH value of human stomach, adjust the pH of the extract to 2.0 with 1mol / LHCL, heat and extract for 1.5 hours, filter, and obtain gastric juice simulated extract, add 6 times of water to the residue to simulate the pH value of human small intestine, adjust the pH of the extract to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heat and extract for 1.5 hours, filter, and combine the two filtrates to obtain a decoction.
[0121] Example 24: Preparation of a drug for treating visual fatigue in video terminals (pills)
[0122] (1) Crushing
[0123] Take the medicinal materials according to the formula ratio and crush them into fine powder.
[0124] (2) Pill making
[0125] Add 50g of refined honey and appropriate amount of water to every 100g of powder to make water-honey pills. Dry them to get pills.
[0126] In order to further verify the feasibility of the present invention, the inventor conducted a series of experiments, as follows:
[0127] 1. Formula Optimization Test
[0128] According to Chinese medicine, all the pulses belong to the eyes, and the liver receives blood and can see. "Qianjin Yaofang·Qiqiao Diseases" states that "overuse of the eyes, such as reading, gambling, etc., is called liver fatigue", which directly attributes this disease to "liver fatigue". Its symptoms include visual fatigue, blurred vision, dry eyes, eye pain, foreign body sensation, red eyes, eye swelling, etc., which are also called "eye fatigue" in contemporary Chinese medicine. Combining the understanding of ancient doctors with today's clinical practice, visual fatigue can be divided into three Chinese medicine syndromes: liver and kidney yin deficiency, liver depression and qi stagnation, and qi and blood deficiency, among which liver and kidney yin deficiency is the main syndrome.
[0129] Liver Yin deficiency and kidney Yin deficiency are liver-kidney Yin deficiency. Liver Yin deficiency is often affected by kidney Yin deficiency, and fire is damaged by liver Yin and kidney Yin, resulting in liver-kidney Yin deficiency. The kidney is the place where essence is stored, and the liver is the organ that stores blood. Liver blood depends on the cultivation of kidney essence, and kidney essence depends on the supplement of liver blood. Only when the eyes are nourished by essence and blood can the vision be sharp. When the kidney is deficient, dizziness and blurred vision will occur. After long-term vision, dry and sore eyes will appear, accompanied by dizziness, tinnitus, sore waist and knees, restlessness, night sweats, insomnia and dreaminess. Liver-kidney Yin deficiency is a syndrome in traditional Chinese medicine, which includes liver blood deficiency, liver Yin deficiency, kidney essence deficiency, and kidney Yin deficiency. When the liver and kidney are deficient at the same time, it is necessary to nourish the liver and kidney, but while nourishing the liver blood and kidney Yin, it is also necessary to warm the yang medicine, so that there is yang in the yin and yin in the yang, and the transformation will be powerful.
[0130] In view of the above TCM theory, the team of the present invention adopted the combination of "liver clearing and eyesight improving drugs + liver tonifying drugs + kidney tonifying drugs + yang warming drugs" to carry out experimental research, and intended to screen out effective formulas that can relieve visual fatigue of video terminals through liver and kidney yin deficiency syndrome mouse models. After consulting research materials and combining clinical medication experience, the preliminary selection of liver clearing and eyesight improving drugs in this study is tea and red green grass, kidney tonifying drugs are mulberry and dog bones, liver tonifying drugs are white peony and cyperus, and yang warming drugs are curculigo and walnut kernels.
[0131] 1. Experimental methods
[0132] 1. Animal husbandry
[0133] (1) Experimental groups
[0134] After 7 days of adaptive feeding, the New Zealand white rabbits were randomly divided into 11 groups, each with 5 rabbits, including a blank control group, a visual fatigue model group, and self-prepared formula groups 1 to 9. The self-prepared formulas are shown in Table 1 below.
[0135] Table 1 Self-made formula
[0136]
[0137]
[0138] (2) Modeling method
[0139] The visual fatigue animal model was established from the first day of the experiment. The blank control group was placed under normal light cycle, day: 100 Lux; night: 0 Lux. In addition to the blank control group, the model group and the self-made formula 1-9 groups were placed under dark light conditions, with a day and night light cycle, day: 30 Lux; night: 0 Lux. 20 white smooth stones with a diameter of about 1 cm were added to the food boxes of New Zealand white rabbits to induce the animals.
[0140] (3) Method of administration
[0141] The medication started from the first day of modeling, and the modeling and medication were carried out simultaneously. The self-prepared decoction equivalent to 2 times the daily dose of adults was given twice a day (8 am and 2 pm). The model group and the blank group were only given appropriate amount of water without medication. The intervention lasted for 28 days.
[0142] 2. Observation methods and detection indicators
[0143] (1) Observation of general status
[0144] Observe the diet, behavior, mental state, hair, urination and defecation of the New Zealand white rabbits.
[0145] (2) Refractive index measurement
[0146] The method used to measure the refractive value of New Zealand white rabbits is the band light retinoscopy. The examiner performs the measurement without knowing the grouping of New Zealand white rabbits. Since New Zealand white rabbits are docile and lively by nature, no anesthesia is required during the measurement. Under dim light conditions, the experimenter grasps the New Zealand white rabbit and exposes the eye to be examined. On days 0 and 28, the examiner holds the test lens at a measuring distance of 50 cm and at intervals of 0.50D to perform retinoscopy on the horizontal and vertical meridians. Astigmatism is calculated as half-equivalent spherical lens. Both eyes are measured 3 times each, and the refractive value (D) is used as the unit, and the average value is taken. The entire operation process is completed by the same examiner (in order to reduce the error caused by measurements by different people).
[0147] (3) Measurement of intraocular pressure
[0148] The intraocular pressure of New Zealand white rabbits was measured by using a contact tonometer. The examiner did not know the grouping of the New Zealand white rabbits. First, 1 drop of proparacaine hydrochloride eye drops was dripped into the surface of the eyeball of the New Zealand white rabbit for surface anesthesia, and the eye was exposed. The changes in the intraocular pressure of each group of New Zealand white rabbits were measured using a contact tonometer on day 0 and day 14. Each eyeball was measured 3 times and the average value was taken. The entire operation was completed by the same examiner.
[0149] (4) Lens thickness and anterior chamber depth measurement
[0150] The lens thickness and anterior chamber depth of New Zealand white rabbits were measured by ophthalmic A-ultrasound biometer. First, 1 drop of proparacaine hydrochloride eye drops was dripped into the surface of both eyes of New Zealand white rabbits for surface anesthesia, and the eyes were exposed. The changes of lens thickness and anterior chamber depth values of each group were detected by A-ultrasound ophthalmic ultrasound biometer on 0 day and 28 day, respectively. Before measurement, alcohol cotton pads were used for wiping and disinfection, and the probe was perpendicular to the corneal vertex. Each eyeball was measured 10 times continuously and the average value was taken. The whole operation process was completed by the same examiner.
[0151] 3. Experimental results
[0152] (1) General examination of New Zealand White rabbits
[0153] During the experiment, the New Zealand white rabbits in the normal control group showed no obvious changes in their diet, behavior, spirit, hair, and urination and defecation; the New Zealand white rabbits in the visual fatigue model group showed symptoms such as weight loss, dry stools, yellow urine, more active reactions and actions, and irritability due to being in a dark environment for a long time and continuously staring at the eye-catching stone; compared with the animals in the model group, the 1-9 drug-treated group showed certain improvements in the above conditions.
[0154] (2) Effect of self-prepared soup on the refractive index of New Zealand white rabbits with visual fatigue
[0155] On the 28th day after modeling and drug administration, compared with the blank control group, the diopter value of the model group increased significantly; compared with the model group, the diopter values of the self-prepared formula 1-9 drug administration groups decreased significantly to varying degrees. The results are shown in Table 2.
[0156] Table 2 Effect of self-made formula on the diopter value of New Zealand white rabbits with visual fatigue
[0157] Group Quantity (pcs) Refraction value on day 28 (D) Blank control group 10 -1.63±0.41 Model Group 10 -2.98±0.45 Recipe 1 10 -1.75±0.57* Recipe 2 10 -2.13±0.46* Recipe 3 10 -2.11±0.51* Recipe 4 10 -1.82±0.49* Recipe 5 10 -2.03±0.52* Recipe 6 10 -2.25±0.43* Recipe 7 10 -1.81±0.61* Recipe 8 10 -2.08±0.42* Recipe 9 10 -2.21±0.48*
[0158] Note: Compared with the model group, *P<0.05
[0159] The test results show that Formula 1 can significantly reduce the refractive power of New Zealand white rabbits, indicating that Formula 1 has obvious pharmacological effects. The pharmacological effects of Formula 4 (excluding mulberries) and Formula 7 (excluding Cyperus rotundus) are equivalent to those of Formula 1, indicating that removing mulberries and Cyperus rotundus from Formula 1 has little effect on the whole formula.
[0160] (3) Effect of self-prepared soup on intraocular pressure in New Zealand white rabbits with visual fatigue
[0161] On the 14th day after modeling and drug administration, compared with the blank control group, the intraocular pressure value of the model group increased significantly; compared with the model group, the intraocular pressure values of the self-prepared formula 1-9 drug administration groups decreased significantly to varying degrees. The results are shown in Table 3.
[0162] Table 3 Effect of self-made formula on intraocular pressure of New Zealand white rabbits with visual fatigue
[0163] Group Quantity (pcs) IOP on day 14 (mmHg) Blank control group 10 8.42±1.45 Model Group 10 13.21±1.84 Recipe 1 10 9.33±1.51* Recipe 2 10 10.87±1.93* Recipe 3 10 10.58±1.62* Recipe 4 10 9.57±1.36* Recipe 5 10 10.39±1.43* Recipe 6 10 10.98±1.52* Recipe 7 10 9.75±1.57* Recipe 8 10 10.38±1.32* Recipe 9 10 11.03±1.67*
[0164] Note: Compared with the model group, *P<0.05
[0165] The test results show that Formula 1 can significantly reduce the intraocular pressure of New Zealand white rabbits, indicating that Formula 1 has obvious pharmacological effects. The pharmacological effects of Formula 4 (excluding mulberries) and Formula 7 (excluding Cyperus rotundus) are equivalent to those of Formula 1, further indicating that subtracting mulberries and Cyperus rotundus from Formula 1 has little effect on the whole formula.
[0166] (4) Effect of self-prepared soup on lens thickness and anterior chamber depth in New Zealand white rabbits with visual fatigue
[0167] On the 14th day after modeling and drug administration, compared with the blank control group, the anterior chamber depth of the New Zealand white rabbits in the model group was significantly reduced, and compared with the model group, the anterior chamber depth of the self-prepared formula 1-9 drug administration group was significantly increased. On the 28th day after treatment, compared with the blank control group, the lens thickness of the New Zealand white rabbits in the model group was significantly reduced; compared with the model group, the lens thickness value of the self-prepared formula 1-9 drug administration group was significantly increased. The results are shown in Table 4.
[0168] Table 4 Effect of self-made formula on lens thickness and anterior chamber depth of New Zealand white rabbits with visual fatigue
[0169] Group Quantity (pcs) Anterior chamber depth on day 14 (mm) Lens thickness on day 28 (mm) Blank control group 10 2.86±0.54 6.73±0.76 Model Group 10 2.17±0.36 4.24±0.61 Recipe 1 10 2.66±0.46* 6.11±0.53* Recipe 2 10 2.42±0.50 5.44±0.56* Recipe 3 10 2.37±0.55 5.30±0.50* Recipe 4 10 2.63±0.51* 5.92±0.51* Recipe 5 10 2.21±0.62 5.23±0.52* Recipe 6 10 2.33±0.48 5.24±0.45* Recipe 7 10 2.59±0.56* 6.01±0.54* Recipe 8 10 2.30±0.62 5.15±0.50* Recipe 9 10 2.61±0.51 5.20±0.48*
[0170] Note: Compared with the model group, *P<0.05
[0171] The experimental results showed that compared with the model group, Formula 1 could significantly increase the anterior chamber depth and lens thickness, indicating that Formula 1 had significant pharmacological effects. The pharmacological effects of Formula 4 (excluding mulberries) and Formula 7 (excluding Cyperus rotundus) were equivalent to those of Formula 1, further indicating that removing mulberries and Cyperus rotundus from Formula 1 had little effect on the whole prescription.
[0172] 4. Conclusion
[0173] Through screening of the New Zealand white rabbit model of visual fatigue, the optimal formula was determined to be: 15g tea, 15g red green grass, 15g dog bone, 10g white peony root, 10g curculigo, and 15g walnut kernel.
[0174] 2. Extraction process research
[0175] The formula of the present invention is composed of 6 ingredients, namely tea leaves, red green grass, dog bones, white peony root, curculigo, and walnut kernels. The Chinese medicine compound is a multivariate and complex system with complex internal chemical components. It is difficult to use the efficacy or pharmacokinetic parameters of a certain component to represent the parameters of the entire Chinese medicine compound. The team of the present invention carried out pharmacological experimental research on the liquid obtained by each extraction method, and compared four different extraction processes, namely water extraction, alcohol extraction, ultrasonic extraction, and semi-bionic extraction, through experiments, and finally selected the best extraction process.
[0176] 1. Preliminary selection of extraction method
[0177] (I) Sample preparation
[0178] A. Water Extraction
[0179] Weigh the medicinal materials according to the formula ratio, add 8 times the amount of water, heat and extract twice, each time for 0.5 hour, filter, concentrate the filtrate and make up to the appropriate volume for use.
[0180] B. Alcohol extraction
[0181] Weigh the medicinal materials according to the formula ratio, add 8 times 60% ethanol, heat and extract twice, each time for 0.5 hour, filter, recover ethanol from the filtrate, concentrate and make up to the appropriate volume for use.
[0182] C. Ultrasonic extraction
[0183] Weigh the medicinal materials according to the formula ratio, add 8 times of water, and perform ultrasonic extraction twice at 60°C, each time for 0.5 hour, filter, concentrate the filtrate and make up to the appropriate volume for later use.
[0184] D. Semi-bionic extraction method
[0185] Weigh the medicinal materials according to the formula ratio, first add 8 times of water to simulate the pH value of human stomach, adjust the pH of the extractant to 2.0 with 1mol / LHCL, heat and extract for 0.5 hour, filter, and obtain gastric juice simulated extract. Add 8 times of water to the residue to simulate the pH value of human small intestine, adjust the pH of the extractant to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heat and extract for 0.5 hour, filter, combine the two filtrates, concentrate and make up to an appropriate amount for use.
[0186] (II) Pharmacological experiments
[0187] 1. Animal husbandry
[0188] (1) Experimental groups
[0189] After 7 days of adaptive feeding, the New Zealand white rabbits were randomly divided into 6 groups, with 5 rabbits in each group, namely blank control group, visual fatigue model group, water extraction group, alcohol extraction group, ultrasonic extraction group, and semi-bionic extraction group.
[0190] (2) Modeling method
[0191] The visual fatigue animal model was established from the first day of the experiment. The blank control group was placed under normal light cycle, day: 100 Lux; night: 0 Lux. Except for the blank control group, the model group and the four experimental groups were placed under dark light conditions, with a day and night light cycle, day: 30 Lux; night: 0 Lux. 20 white smooth stones with a diameter of about 1 cm were added to the food boxes of New Zealand white rabbits to induce the animals.
[0192] (3) Method of administration
[0193] The drug administration started from the first day of modeling, and the modeling and drug administration were carried out simultaneously. The drug solution prepared by the above extraction method was administered to each experimental group twice a day (8 am and 2 pm). The model group and the blank group were only given appropriate amount of water without drug administration. The intervention lasted for 28 days.
[0194] 2. Detection indicators
[0195] (1) Measurement of intraocular pressure
[0196] The intraocular pressure of New Zealand white rabbits was measured by using a contact tonometer. The examiner did not know the grouping of the New Zealand white rabbits. First, 1 drop of proparacaine hydrochloride eye drops was dripped into the surface of the eyeball of the New Zealand white rabbit for surface anesthesia, and the eye was exposed. The changes in the intraocular pressure of each group of New Zealand white rabbits were measured using a contact tonometer on day 0 and day 14. Each eyeball was measured 3 times and the average value was taken. The entire operation was completed by the same examiner.
[0197] (2) Lens thickness and anterior chamber depth measurement
[0198] The lens thickness and anterior chamber depth of New Zealand white rabbits were measured by ophthalmic A-ultrasound biometer. First, 1 drop of proparacaine hydrochloride eye drops was dripped into the surface of both eyes of New Zealand white rabbits for surface anesthesia, and the eyes were exposed. The changes of lens thickness and anterior chamber depth values of each group were detected by A-ultrasound ophthalmic ultrasound biometer on 0 day and 28 day, respectively. Before measurement, alcohol cotton pads were used for wiping and disinfection, and the probe was perpendicular to the corneal vertex. Each eyeball was measured 10 times continuously and the average value was taken. The whole operation process was completed by the same examiner.
[0199] 3. Experimental results
[0200] (1) Effects of the four experimental groups on intraocular pressure in New Zealand white rabbits with visual fatigue
[0201] On the 14th day after modeling and drug administration, compared with the blank control group, the intraocular pressure value of the model group increased significantly; compared with the model group, the intraocular pressure values of the four experimental groups decreased to varying degrees. The results are shown in Table 5.
[0202] Table 5 Effects of the four experimental groups on intraocular pressure of New Zealand white rabbits with visual fatigue
[0203] Group Quantity (pcs) IOP on day 14 (mmHg) Blank control group 5 8.55±1.39 Model Group 5 13.34±1.81 Water extraction group 5 9.98±1.47 Alcohol extraction group 5 10.87±1.93 Ultrasonic extraction group 5 10.12±1.54 Semi-bionic extraction group 5 9.23±1.26
[0204] (2) Effects of the four experimental groups on lens thickness and anterior chamber depth in New Zealand white rabbits with visual fatigue
[0205] On the 14th day after modeling and drug administration, compared with the blank control group, the anterior chamber depth of the New Zealand white rabbits in the model group was significantly reduced, and compared with the model group, the anterior chamber depth of the four experimental drug administration groups was significantly increased. On the 28th day after treatment, compared with the blank control group, the lens thickness of the New Zealand white rabbits in the model group was significantly reduced; compared with the model group, the lens thickness values of the four experimental drug administration groups were significantly increased. The results are shown in Table 6.
[0206] Table 6 Effects of the four experimental groups on lens thickness and anterior chamber depth in New Zealand white rabbits with visual fatigue
[0207] Group Quantity (pcs) Anterior chamber depth on day 14 (mm) Lens thickness on day 28 (mm) Blank control group 5 2.88±0.57 6.73±0.76 Model Group 5 2.08±0.42 4.24±0.61 Water extraction group 5 2.53±0.38 6.13±0.58 Alcohol extraction group 5 2.31±0.56 5.57±0.49 Ultrasonic extraction group 5 2.39±0.55 5.89±0.54 Semi-bionic extraction group 5 2.68±0.50 6.52±0.52
[0208] The test results show that compared with the model group, the intraocular pressure values of the four experimental groups were significantly reduced, and the anterior chamber depth value and lens thickness were increased. Among them, the semi-bionic extraction group was more effective than the other three experimental groups, indicating that it is feasible to extract the formula by the semi-bionic extraction method, and the pharmacological effect is stronger than the other extraction methods. Therefore, the extraction process of the present invention determines to adopt the semi-bionic extraction method.
[0209] (II) Optimization of process parameters for semi-bionic extraction method
[0210] (1) Preferred indicators and scoring criteria
[0211] A. Pharmacological Action
[0212] Considering that the treatment of diseases by traditional Chinese medicine is the result of the comprehensive effects of its components, it is not comprehensive to use a single component as an evaluation indicator. Comprehensive pharmacological experiments are needed to demonstrate the comprehensive pharmacological effects of the drug. Therefore, the pharmacological effect can be used as one of the evaluation indicators of the orthogonal experiment. The intraocular pressure value, lens thickness and anterior chamber depth value of New Zealand white rabbits are used as indicators, and compared with the model group and the blank group. The blank group is taken as the full score, and the scores of the remaining experimental groups are calculated. The full score is 40 points.
[0213] B. Total flavonoids extraction rate
[0214] According to modern pharmacological research, the important material basis for the therapeutic effect of this formula is the flavonoid components in the formula. Therefore, the extraction rate of total flavonoids can be used as one of the evaluation indicators of the orthogonal test. The test group with the highest extraction rate is the full score, and the scores of the remaining experimental groups are calculated. The full score is 40 points.
[0215] C.60% ethanol solid content
[0216] There are 6 medicinal materials in the formula, and it is difficult to use the extraction amount of the effective ingredients of each medicinal material as an evaluation indicator one by one. After consulting the information and comprehensive consideration, the orthogonal test extract can be concentrated, and ethanol can be added to make the alcohol content reach 60%, remove impurities such as gum and starch, and retain effective substances such as flavonoids, alkaloids, and polyphenols. In other words, the amount of solids in 60% ethanol represents the amount of extracted effective substances. Therefore, the solid content of 60% ethanol can also be determined and used as one of the evaluation indicators of the orthogonal test. The test group with the highest solid content is the full score, and the scores of the remaining experimental groups are calculated, with a full score of 20 points.
[0217] (2) Experimental methods
[0218] A. Pharmacological Action
[0219] The drug solution extracted by the orthogonal test was used for experiments according to the above-mentioned pharmacological experimental method, and the intraocular pressure value, lens thickness and anterior chamber depth value of New Zealand white rabbits were used as indicators to compare with the model group and the blank group.
[0220] B. Total flavonoids extraction rate
[0221] Preparation of reference solution: Take 50 mg of rutin reference, weigh accurately, place in a 25 ml volumetric flask, add appropriate amount of methanol, place in a water bath and heat slightly to dissolve, cool, add methanol to scale, shake well. Accurately measure 10 ml, place in a 100 ml volumetric flask, add water to scale, shake well, and obtain (each 1 ml contains 0.2 mg of rutin).
[0222] Preparation of standard curve: Accurately measure 1ml, 2ml, 3ml, 4ml, 5ml and 6ml of the reference solution, place them in 25ml volumetric flasks respectively, add water to 6.0ml each, add 1ml of 5% sodium nitrite solution, mix well, let stand for 6 minutes, add 1ml of 10% aluminum nitrate solution, shake well, let stand for 6 minutes, add 10ml of sodium hydroxide test solution, add water to the scale, shake well, let stand for 15 minutes, use the corresponding reagent as blank, measure the absorbance at a wavelength of 500nm according to the UV-visible spectrophotometry, and draw a standard curve with absorbance as the ordinate and concentration as the abscissa.
[0223] Determination method: Accurately measure 5 ml of the drug solution of each orthogonal test and place it in a 25 ml volumetric flask. According to the method under the standard curve preparation, starting from "add 1 ml of 5% sodium nitrite solution", determine the absorbance according to the law, read the weight (μg) of rutin in the test solution from the standard curve, and calculate to get the result.
[0224] Total flavonoid extraction rate = total flavonoid content after extraction ÷ theoretical total flavonoid content × 100%
[0225] C.60% ethanol solid content
[0226] Accurately pipette 25 ml of the drug solution of each orthogonal test, accurately add 43 ml of 95% ethanol to make the alcohol content of the solution reach 60%, let it stand overnight, filter, place the filtrate in an evaporating dish that has been dried to constant weight, evaporate to dryness in a water bath, dry the residue at 105°C for 3 hours, take it out, place it in a desiccator for 30 minutes, weigh it, and calculate the amount of solids.
[0227] (3) Orthogonal test
[0228] The factors that affect the semi-bionic extraction effect mainly include the amount of water added, the extraction time in simulated gastric fluid, the extraction time in simulated intestinal fluid, etc. The three factors that have a greater impact on the extraction effect, namely the amount of water added (A), the extraction time in simulated gastric fluid (B) and the extraction time in simulated intestinal fluid (C), were determined as the investigation factors. According to the preliminary data, each factor was taken at 3 levels to carry out orthogonal experiments. The factor levels are shown in Table 7, the test results are shown in Table 8, and the variance analysis is shown in 9.
[0229] Table 7 Extraction and investigation of orthogonal test factors and levels
[0230]
[0231] Table 8 Orthogonal experimental design and results of extraction investigation
[0232]
[0233] Table 9 Results of variance analysis of extraction investigation
[0234]
[0235] Note: F 0.05 (2, 2) = 19
[0236] From the orthogonal test results in Table 8, it can be seen that the influence of each factor on the extraction effect is B>C>A, A2>A3>A1 in factor A, B2>B3>B1 in factor B, C3>C1>C2 in factor C, and the optimal extraction process parameters are A2B2C3. Combined with the variance analysis in Table 9, it can be seen that, except for factor A, factors B and C both have significant effects. From the perspective of cost saving, A1 can be selected as the optimal parameter. Therefore, the optimal extraction process parameters are: weigh the medicinal materials according to the formula ratio, first add 6 times of water to simulate the pH value of human stomach, adjust the pH of the extractant to 2.0 with 1mol / LHCL, heat and extract for 60 minutes, filter, and obtain gastric juice simulation extract, add 6 times of water to the residue to simulate the pH value of human small intestine, adjust the pH of the extractant to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heat and extract for 90 minutes, filter, and combine the two filtrates.
[0237] 3. Verification of optimal parameters of semi-bionic extraction process
[0238] According to the formula ratio, tea leaves, red green grass, dog bones, white peony root, curculigo and walnut kernel were taken, a total of 3 parts, and extracted according to the optimal extraction process parameters selected above, and the extract was concentrated and fixed to an appropriate volume. The pharmacological effects, total flavonoid extraction rate and 60% ethanol solid content were determined, and the results are shown in Table 10.
[0239] Table 10 Verification results of optimal extraction process parameters
[0240]
[0241] The verification results show that the extract obtained by this extraction process has good indicators and the process is stable, which means that this extraction process is reasonable and feasible.
[0242] 3. Clinical efficacy verification
[0243] In order to screen out the best formula for clinical efficacy, the present invention team further carried out clinical efficacy verification experiments.
[0244] 1. General Information
[0245] (1) Clinical data
[0246] A total of 90 patients with eye fatigue caused by video terminals admitted to our hospital from July 2022 to July 2023 were selected and divided into a control group and an observation group according to the random number table method, with 45 cases in each group. There were 23 male and 22 female patients in the control group, 90 eyes; the youngest was 18 years old and the oldest was 57 years old, with an average age of (38.28±5.25) years old; the video terminal was used for 1 to 6 years, with an average of (4.12±1.61) years; the daily video terminal was used for 6 to 11 hours, with an average of (8.34±2.48) hours. There were 24 male and 21 female patients in the observation group, 90 eyes; the youngest was 20 years old and the oldest was 56 years old, with an average of (38.11±5.46) years old; the video terminal was used for 2 to 7 years, with an average of (4.62±1.73) years; the daily video terminal was used for 5 to 11 hours, with an average of (8.71±2.40) hours. The baseline data of the two groups of patients were balanced and comparable (P>0.05).
[0247] (2) Inclusion criteria
[0248] A: Those who meet the diagnostic criteria of the Expert Consensus on Diagnosis and Treatment of Visual Asthenopia (2014) are those who experience eye symptoms such as itchy eyes and dry eyes after long-term use of electronic products such as computers, mobile phones, and televisions. In severe cases, they may be accompanied by headaches, dizziness, and insomnia.
[0249] B: Aged ≥ 18 years, continuous use of video terminals for > 5 hours per day;
[0250] C: The patient is informed and consents.
[0251] (3) Exclusion criteria
[0252] A: Patients with eye fatigue caused by other reasons;
[0253] B: Patients with other eye diseases;
[0254] C: Those who received relevant treatment 2 weeks before enrollment;
[0255] D: Those who are allergic to digitalis septin or the ingredients of this formula;
[0256] E: Patients with mental disorders;
[0257] D: Pregnant or lactating women.
[0258] 2. Methods
[0259] (1) Treatment methods
[0260] Both groups of patients were treated with esculin digoxin eye drops (Germany Vision Turin Pharmaceutical Co., Ltd., National Medicine Standard H20130295), 1 drop each time, 4 times / day, and the treatment time was 4 weeks. The observation group was given an eye protection prescription optimized by the present invention team, which consisted of 15g tea leaves, 15g red green grass, 15g dog bone, 10g white peony root, 10g curculigo, and 15g walnut kernel. The mixture was prepared according to the preparation method of Example 11, one dose per day, and the taking time was 4 weeks.
[0261] (2) Efficacy criteria
[0262] The treatment is considered markedly effective when the eye symptoms disappear and the continuous close-range eye use time is >45 minutes; the treatment is considered effective when the eye symptoms are alleviated and the continuous close-range eye use time is >30 minutes; the treatment is considered unchanged or worsened.
[0263] (3) Observation indicators
[0264] A: Ocular symptom score
[0265] Before treatment and 4 weeks after treatment, the ocular symptoms (itchy eyes, dry eyes, eye pain, foreign body sensation, blurred vision, photophobia, and tearing) of the two groups of patients were scored on a 4-point scale according to the severity, including no symptoms (0 points), mild symptoms (2 points), moderate symptoms (4 points), and severe symptoms (6 points).
[0266] B: Ocular Surface Disease Index (OSDI) score
[0267] Various aspects are evaluated including eye symptoms, visual function, environmental triggers, etc., with a total score of 100 points. The higher the score, the more serious the condition.
[0268] C: Tear breakup time (BUT) test
[0269] A drop of fluorescein is instilled into the conjunctival sac to stain the tear film. The patient is asked to look forward and blink. The time when the first dry black spot appears on the tear film is the BUT.
[0270] D: Tear secretion test (SIt)
[0271] Take a filter paper strip with a length of 3.5 cm and a width of 0.5 cm, and place it on the dome of the lower eyelid 1 / 3, being careful not to touch the cornea. After closing both eyes lightly for 5 minutes, take it out and measure the infiltrated length.
[0272] (4) Statistical methods
[0273] SPSS22.0 statistical data were used; count data and measurement data were expressed as (%) and (x±s) and subjected to chi-square t test respectively;
[0274] P<0.05 indicated that the difference was statistically significant.
[0275] 3. Results
[0276] (1) Comparison of the therapeutic effects between the two groups of patients is shown in Table 11.
[0277] Table 11 Comparison of efficacy between the two groups of patients
[0278]
[0279] Note: Compared with the control group, *P<0.05
[0280] The experimental results show that the effective rate of the observation group is significantly higher than that of the control group, especially the number of markedly effective cases in the observation group is significantly higher than that in the control group, indicating that the formula of the present invention has a definite therapeutic effect.
[0281] (2) Comparison of ocular symptom scores between the two groups before and after treatment
[0282] See Table 12-Table 13.
[0283] Table 12 Comparison of eye symptom scores between the two groups of patients before and after treatment (1)
[0284]
[0285]
[0286] Note: Compared with before treatment, *P<0.05; compared with the control group, △P<0.05
[0287] Table 13 Comparison of eye symptom scores between the two groups of patients before and after treatment (2)
[0288]
[0289] Note: Compared with before treatment, *P<0.05; compared with the control group, △P<0.05
[0290] The experimental results showed that all indicators of eye symptoms of both groups of patients were significantly improved after treatment (P < 0.05), and the improvement effect was more obvious in the observation group than in the control group (P < 0.05).
[0291] (3) Comparison of OSDI between the two groups before and after treatment
[0292] See Table 14.
[0293] Table 14 Comparison of OSDI between the two groups of patients before and after treatment
[0294]
[0295] Note: Compared with before treatment, *P<0.05; compared with the control group, △P<0.05
[0296] The experimental results showed that OSDI of both groups of patients improved significantly after treatment (P<0.05), and the improvement effect was more obvious in the observation group than in the control group (P<0.05).
[0297] (4) Comparison of BUT and SIt between the two groups before and after treatment
[0298] See Table 15.
[0299] Table 15 Comparison of BUT and SIt between the two groups of patients before and after treatment (2)
[0300]
[0301] Note: Compared with before treatment, *P<0.05; compared with the control group, △P<0.05
[0302] The experimental results showed that BUT and SIt of both groups of patients were significantly improved after treatment (P<0.05), and the improvement effect was more obvious in the observation group than in the control group (P<0.05).
[0303] (5) Comparison of safety between the two groups of patients before and after treatment
[0304] No adverse reactions were found in either group of patients during the treatment.
[0305] 4. Conclusion
[0306] In summary, the drug combination of the present invention is effective in treating visual fatigue of video terminals and has high safety.
[0307] Although the present invention has been described in detail above by means of general description, specific implementation methods and experiments, it is obvious to those skilled in the art that some modifications or improvements may be made to the present invention. Therefore, these modifications or improvements made without departing from the spirit of the present invention all fall within the scope of protection claimed by the present invention.
Claims
1. A composition for treating visual fatigue in a video terminal, characterized in that: The raw material components are composed of the following by weight: 10-20 parts of tea leaves, 10-20 parts of red and green grass, 10-20 parts of dog bones, 5-15 parts of white peony root, 5-15 parts of curculigo, and 10-20 parts of walnut kernels.
2. The composition according to claim 1, characterized in that The raw material components are composed of the following by weight: 12-18 parts of tea leaves, 12-18 parts of red and green grass, 12-18 parts of dog bones, 6-14 parts of white peony root, 6-14 parts of curculigo, and 12-18 parts of walnut kernels.
3. The composition according to claim 2, characterized in that The raw material components are composed of the following by weight: 14-16 parts of tea leaves, 14-16 parts of red and green grass, 14-16 parts of dog bones, 8-12 parts of white peony root, 8-12 parts of curculigo, and 14-16 parts of walnut kernels.
4. The composition according to claim 3, characterized in that The invention is composed of the following raw material components by weight: 15 parts of tea leaves, 15 parts of red green grass, 15 parts of dog bones, 10 parts of white peony roots, 10 parts of curculigo orchioides, and 15 parts of walnut kernels.
5. A method for preparing the composition according to any one of claims 1 to 4, characterized in that: Weigh tea leaves, red green grass, dog bones, white peony root, curculigo orchioides, and walnut kernels according to the proportion of the formula, first add 6-10 times of water, adjust the pH of the extractant to 2.0 with 1mol / LHCL, heat and extract for 0.5-1.5h, filter to obtain an extract, add 6-10 times of water to the residue, adjust the pH of the extractant to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heat and extract for 0.5-1.5h, filter, combine the two filtrates, concentrate, and add conventional pharmaceutical excipients to prepare a corresponding preparation.
6. The method for preparing the composition according to claim 5, characterized in that: Weigh tea leaves, red green grass, dog bones, white peony root, curculigo orchioides, and walnut kernels according to the proportion of the formula, first add 6 times of water, adjust the pH of the extractant to 2.0 with 1 mol / L HCL, heat and extract for 1.5 hours, filter, and obtain an extract, add 6 times of water to the residue, adjust the pH of the extractant to 7.5 with disodium hydrogen phosphate-citric acid buffer solution, heat and extract for 1.5 hours, filter, concentrate, combine the two filtrates, and add conventional pharmaceutical excipients to prepare a pharmaceutically acceptable preparation.
7. The method for preparing the composition according to claim 6, characterized in that: The pharmaceutically acceptable preparation is a solid preparation or a liquid preparation.
8. The method for preparing the composition according to claim 7, characterized in that: The solid preparations include, but are not limited to, granules, capsules, tablets, and pills.
9. The method for preparing the composition according to claim 7, characterized in that: The liquid preparations include, but are not limited to, decoctions and mixtures.
10. Use of the composition according to any one of claims 1 to 4 or the product prepared by the preparation method according to any one of claims 5 to 9 in preparing a drug for treating visual fatigue of video terminals.
